Chemours, Dupont De Nemours, and Corteva have announced a $110 million settlement with the U.S. state of Ohio to resolve claims linked to toxic "forever chemicals." This agreement aims to address concerns surrounding per- and polyfluoroalkyl substances (PFAS).
Nasdaq reported that the chemical has been associated with various health risks. The settlement covers costs related to the release of PFAS from the companies' facilities, including the Washington Works site situated along the Ohio-West Virginia border, as per Reuters.
Responsibility Distribution for Settlement Costs
According to the agreement, Chemours, a spin-off of DuPont, will bear 50% of the settlement costs, while DuPont will contribute approximately $39 million. Corteva, on the other hand, is expected to cover the remaining expenses. The resolution brings an end to Ohio's claims concerning the release of PFAS, affording the state an opportunity to address this issue comprehensively.
The resolution of the Ohio settlement emphasizes the importance of addressing the wide-reaching implications of PFAS contamination.
Notably, the settlement between the companies and Ohio has triggered a contingency provision outlined in Delaware's 2021 PFAS settlement with the same entities.
This provision requires an additional payment of $25 million to the state of Delaware and the original $50 million settlement if a similar agreement is reached within eight years with another state, amounting to over $50 million. This provision underlines the accountability held by chemical manufacturers in addressing the concerns associated with PFAS contamination.
Legal Battles Surrounding PFAS
Chemical manufacturers have faced numerous lawsuits in recent years regarding alleged PFAS contamination. In a significant ruling, a U.S. appeals court rejected a lower court's decision that would have allowed approximately 11.8 million Ohio residents to sue 10 PFAS manufacturers as a collective group. The legal landscape demonstrates the complexity surrounding PFAS-related claims and the efforts to hold responsible parties accountable for their actions.
In June, 3M agreed to a $10.3 billion settlement to address hundreds of claims alleging the company had contaminated public drinking water with PFAS. Similarly, Chemours, DuPont, and Corteva reached a separate settlement with U.S. water providers, amounting to $1.19 billion.
These settlements underscore the growing recognition within the industry regarding the need to address PFAS-related concerns and the responsibility manufacturers bear in ensuring the safety of their products and practices.
Photo: DuPont Newsroom


SEC Seeks ISS Client Voting Records in Proxy Adviser Probe
Suzuki Targets Faster Car Development to Keep Pace With Chinese Rivals
Trump Administration Prepares Sanctions Against Entire ICC
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Almonty Industries Shares Jump 8% After Stifel Sets $25 Target
Mahmoud Khalil Sues Columbia Over Alleged Pro-Palestinian Harassment
US Supreme Court Revives Trump Administration Voter Citizenship Database
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
France Keeps Top Health Alert as Officials Brace for Another Heatwave
US Appeals Court Upholds Anthropic AI Supply Chain Ban
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Rodrigo Duterte Makes First Public Appearance at ICC in 18 Months
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe
Paramount Skydance Faces $30 Million Film Penalty in Warner Bros. Deal
Dubai’s connectivity remains strong in an uncertain world 



